2,600
Participants
Start Date
January 1, 2000
Primary Completion Date
October 1, 2024
Study Completion Date
December 1, 2024
RECRUITING
Because this study is a response to real-world patient treatment and outcomes, Shijiazhuang
Tianjin Medical University Cancer Institute and Hospital
OTHER
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Fujian Cancer Hospital
OTHER_GOV
Fudan University
OTHER
Shandong Cancer Hospital and Institute
OTHER
Hebei Medical University Fourth Hospital
OTHER